Allarity Therapeutics Inc. (NASDAQ: ALLR) announced it has closed a $20 million non-convertible debt financing with Streeterville Capital. The clinical-stage ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE